We are live on
!
Find out more
ASA
Armstrong Shaw Associates Portfolio holdings
AUM
$95.2M
1-Year Est. Return
23.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.11%
1 Year Est. Return
+23.67%
3 Year Est. Return
+51.2%
5 Year Est. Return
+82.8%
10 Year Est. Return
+225.63%
AUM
$120M
AUM Growth
-$3.29M
(-2.7%)
Cap. Flow
-$1.09M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
61.71%
Holding
44
New
1
Increased
–
Reduced
13
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$203K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$271K |
| 2 |
Gilead Sciences
GILD
|
+$214K |
| 3 |
Constellation Brands
STZ
|
+$193K |
| 4 |
Apple
AAPL
|
+$101K |
| 5 |
UnitedHealth
UNH
|
+$96.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.62% |
| 2 | Financials | 21.79% |
| 3 | Healthcare | 19.05% |
| 4 | Communication Services | 9.85% |
| 5 | Consumer Discretionary | 9.02% |
Similar funds
AEPLI
GG
VI
TAM
WCM
QT
OC
KC
Armstrong Shaw Associates's Q1 2022 Portfolio in Review
As of Q1 2022, Armstrong Shaw Associates held 44 positions worth $120M, down 2.7% from $123M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 4.5%. Armstrong Shaw Associates opened 1 new position and exited 1, leaving the 44-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Armstrong Shaw Associates's largest Q1 2022 buy was RTX Corp: 2,138 shares worth $212K.
- Armstrong Shaw Associates's biggest Q1 2022 reduction was Microsoft, cutting an estimated $271K.
- Armstrong Shaw Associates fully exited Gilead Sciences in Q1 2022, selling an estimated $214K.
- Armstrong Shaw Associates's ten largest holdings make up 62% of its $120M portfolio in Q1 2022.
- Armstrong Shaw Associates opened 1 new position and closed 1 in Q1 2022.
- Armstrong Shaw Associates's portfolio value fell 2.7% quarter-over-quarter to $120M.
Based on Armstrong Shaw Associates's 13F filing for Q1 2022, filed 21 Apr 2022.